Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
Authors:
Top Cited Papers
- 1 October 2015
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 16 (13) , 1380-1388
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?The Breast, 2011
- Surgery of the primary tumor does not improve survival in stage IV breast cancerBreast Cancer Research and Treatment, 2011
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosisEuropean Journal of Surgical Oncology, 2009
- Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional RadiotherapyJournal of Clinical Oncology, 2009
- Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survivalBreast Cancer Research and Treatment, 2008
- Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor MetastasisAnnals of Surgical Oncology, 2008
- Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at DiagnosisJournal of Clinical Oncology, 2006
- Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endotheliumInternational Journal of Cancer, 2004
- Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined AnalysisJournal of Urology, 2004
- Tumor cell proliferation and sequential chemotherapy after partial tumor resection in C3H/HeJ mammary tumorsBreast Cancer Research and Treatment, 1982